https://orcid.org/0000-0001-6083-0952
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sara Cacciapuoti, Luca Potestio, Gianluca Guerrasio, Gabriella Fabbrocini, Massimiliano Scalvenzi, Angelo Ruggiero, Giuseppina Caiazzo & Matteo Megna. (2023) Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas. Clinical, Cosmetic and Investigational Dermatology 16, pages 2637-2644.
Read now
Read now
Matteo Megna, Elisa Camela, Angelo Ruggiero, Teresa Battista, Fabrizio Martora, Sara Cacciapuoti & Luca Potestio. (2023) Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?. Clinical, Cosmetic and Investigational Dermatology 16, pages 1677-1690.
Read now
Read now
Luca Mastorino, C. Cariti, S. Susca, S. Boskovic, C. Aquino, M. Ortoncelli, E. Stroppiana, A. Verrone, P. Dapavo, P. Quaglino & Simone Ribero. (2022) Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks. Journal of Dermatological Treatment 33:8, pages 3211-3213.
Read now
Read now
Caterina Lanna, Sara Lambiase, Ruslana Gaeta Shumak, Cristiana Borselli, Terenzio Cosio, Annunziata Dattola, Luca Bianchi & Elena Campione. (2022) Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology. Expert Review of Clinical Pharmacology 15:10, pages 1209-1224.
Read now
Read now
Lin Chen, Jie Li, Ying Yao, Shanlong Wang, Shuangjin Zheng, Xinggang Ju & Bin Zhang. (2021) Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris. Bioengineered 12:1, pages 1838-1850.
Read now
Read now
Articles from other publishers (11)
Peng Zhang, Yuwen Su, Siying Li, Hui Chen, Ruifang Wu & Haijing Wu. (2023) The roles of T cells in psoriasis. Frontiers in Immunology 14.
Crossref
Crossref
Congjun Jiang, Yu Du, Xiaoyan Liu, Jingjing Wang, Cuizhu Ge, Jingyue Xu, Shuoxiong Wang, Benke Li, Gege Zhu, Wanlu Zhang, Qiaoxiao Qian, Chi Ma, Xiangyang Zhu, Yifan Zhan & Yongmin Yang. (2023) Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis. British Journal of Dermatology.
Crossref
Crossref
Chika Ohata, Yasumasa Kanai, Kenta Murotani, Fumikazu Yamazaki, Hidetoshi Takahashi, Yayoi Tada, Tomotaka Mabuchi, Yoko Mizutani, Takanobu Nomura & Shinichi Imafuku. (2023) Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study. Dermatology and Therapy 13:4, pages 1039-1052.
Crossref
Crossref
Congjun Jiang, Huan Zhou, Wanlu Zhang, Yu Xia, Baiyong Li, Xiang Ni, Guoqin Wang, Wenhui Zhang, Benchao Chen, Zhimei He, Min Zhang, Rui Chen, Hongzhong Jin & Liehua Deng. (2022) Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study. Dermatology and Therapy 13:2, pages 555-567.
Crossref
Crossref
Ruth Rodríguez-Montaño, Alondra del Carmen Ruiz-Gutiérrez, Vianeth María del Carmen Martínez-Rodríguez, Juan Ramón Gómez-Sandoval, Juan Manuel Guzmán-Flores, Julieta Sarai Becerra-Ruiz, Ana Lourdes Zamora-Perez & Celia Guerrero-Velázquez. (2022) Levels of IL-23/IL-17 Axis in Plasma and Gingival Tissue of Periodontitis Patients According to the New Classification. Applied Sciences 12:16, pages 8051.
Crossref
Crossref
Bowen Li, Li Yang, Feng Bai, Bainan Tong & Xiaoli Liu. (2022) Indications and effects of biological agents in the treatment of noninfectious uveitis. Immunotherapy 14:12, pages 985-994.
Crossref
Crossref
Karen J. L. Choo & Yi Wei Yeo. 2022. Drug Eruptions. Drug Eruptions
283
302
.
Silvia Vidal, Lluís Puig, José-Manuel Carrascosa-Carrillo, Álvaro González-Cantero, José-Carlos Ruiz-Carrascosa & Antonio-Manuel Velasco-Pastor. (2021) From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. International Journal of Molecular Sciences 22:13, pages 6740.
Crossref
Crossref
Miguel Nogueira, Amy S. Paller & Tiago Torres. (2021) Targeted Therapy for Pediatric Psoriasis. Pediatric Drugs 23:3, pages 203-212.
Crossref
Crossref
M. Nogueira, R.B. Warren & T. Torres. (2020) Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change. Journal of the European Academy of Dermatology and Venereology 35:4, pages 824-834.
Crossref
Crossref
Helena Iznardo & Lluís Puig. (2021) Dual inhibition of IL-17A and IL-17F in psoriatic disease. Therapeutic Advances in Chronic Disease 12, pages 204062232110378.
Crossref
Crossref